Q&M Dental Group (Singapore) holds a 32.78% stake in Aoxin Q&M Dental Group
Q&M Dental Group (Singapore) has called for an EGM of its associate company, Aoxin Q&M 1d4
Dental Group, to remove executive director Dr Ong Siew Hwa.
The former holds a 32.78% stake in the latter.
As indicated in its requisition letter of Feb 17, Acumen Diagnostics, under Aoxin and managed by Dr Ong, is no longer in operations as its clinical laboratory licence has expired.
"It is suggested that there is no longer any requirement for Dr Ong to manage the business of Acumen" and "no commercial benefit" for her to remain as a director.
Q&M further adds that Dr Ong has not resigned from her position as a director of Aoxin despite being "obliged" to do so under a service agreement between her and Aoxin.
Q&M shares closed at 28 cents on Feb 17, up 1.79% for the day; Aoxin shares last traded at 4.2 cents.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。